XML 44 R32.htm IDEA: XBRL DOCUMENT v3.8.0.1
Share-Based Compensation (Tables)
3 Months Ended
Sep. 30, 2017
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Options Outstanding

A summary of the stock option activity under the Company’s plans for the three months ended September 30, 2017 is as follows:

 

 

 

Number

of

shares

 

 

Weighted

average

exercise

price

 

Options outstanding at June 30, 2017

 

 

8.0

 

 

$

24.67

 

Options granted

 

 

 

 

$

 

Less:

 

 

 

 

 

 

 

 

Options exercised

 

 

(0.4

)

 

$

22.75

 

Options canceled or expired

 

 

(0.1

)

 

$

26.56

 

Options outstanding at September 30, 2017

 

 

7.5

 

 

$

24.77

 

Options exercisable at September 30, 2017

 

 

7.5

 

 

$

24.77

 

 

Schedule of Share-Based Compensation Arrangement by Share Based Payment Award Restricted Stock Units Outstanding

A summary of the RSU activity under the Company’s plans for the three months ended September 30, 2017 is as follows:

 

 

 

Number

of

shares

 

 

Weighted

average

grant date

fair value

 

RSUs outstanding at June 30, 2017

 

 

2.0

 

 

$

33.02

 

RSUs granted

 

 

1.0

 

 

$

32.56

 

Less:

 

 

 

 

 

 

 

 

RSUs vested

 

 

(0.5

)

 

$

35.16

 

RSUs canceled

 

 

(0.1

)

 

$

25.93

 

RSUs outstanding at September 30, 2017

 

 

2.4

 

 

$

32.84

 

 

Schedule of Share-Based Compensation Recognized in Consolidated Statements of Operations

Share-based compensation expense recognized and included in the condensed consolidated statements of income and comprehensive income was allocated as follows:

 

 

 

Three months ended

 

 

 

September 30,

 

 

 

2017

 

 

2016

 

Cost of molecular diagnostic testing

 

$

0.2

 

 

$

0.2

 

Cost of pharmaceutical and clinical services

 

 

0.1

 

 

 

0.1

 

Research and development expense

 

 

0.8

 

 

 

1.6

 

Selling, general, and administrative expense

 

 

5.3

 

 

 

5.9

 

Total share-based compensation expense

 

$

6.4

 

 

$

7.8